Technology

The Silver Bullet

light therapy
We’ve developed a light-activated nanomedicine approach that destroys cancer cells, leaving healthy tissue unharmed. Our mission is to make cancer treatment safer and more adaptable for a wide range of cancers.
Encapsulated Precision 
➊

We start with tiny silver nanoclusters—so small, they are invisible even under a microscope—and wrap them in a layer of DNA. This clever design keeps the particles safe ensuring they won’t harm healthy cells. 

Entering the Nucleus
 ➋
These 2-3 nm nanoclusters, easily enter cancer cells and make their way to the cell’s nucleus.
Light Activation
➌
Once the nanoclusters reach the nucleus, we use a specific light to activate them. The light causes the DNA to release the silver particles, right at the core of the cancer cell, where the treatment can be most effective.
Controlled Impact
➍
The silver particles deliver a controlled, targeted spike of toxicity that damages the cancer cell’s DNA, causing cell death while leaving surrounding healthy cells intact.
Disrupting DNA
➎

Our approach tangles up the cancer cell’s DNA, making it impossible for the cell to survive. This process only affectes the cancer cells, reducing the side effects often seen with other treatments.

Why are we unique?

Unlike traditional treatments that affect both cancerous and healthy cells, our drug is activated only inside cancer cells. By using light to control when and where the treatment occurs, we only attack cancer cells, resulting in fewer side effects and better outcomes for patients.

A Versatile Platform

GenLumina’s light-activated nanomedicine is not just a treatment but a platform. Our drug is a payload for all targeting therapeutics using peptides or antibodies, offering a versatile foundation for a wide range of cancer treatments.

Onderscheid maken in targeting / image-guided.

 

ADC

PDC

Standalone drug

Our technology doesn’t just treat cancer;
it’s designed to reshape we manage cancer globally.

CTA Science Deck opvragen